Who owns Mozart Therapeutics?

Mozart Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2021.

When did Sofinnova Partners acquire Mozart Therapeutics?

Sofinnova Partners acquired Mozart Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Mozart Therapeutics

Mozart Therapeutics

Biotech·

US·Active·5yr hold

Mozart Therapeutics is a healthcare / biotech company, headquartered in United States.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited States

SectorHealthcare / Biotech

US company developing disease-modifying therapies for autoimmune and inflammatory diseases targeting a novel regulatory immune pathway.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings